LXRX FY 2019 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$322M+409.5% YoY

Gross Profit

$319M99.0% margin

Operating Income

$141M43.9% margin

Net Income

$130M40.4% margin

EPS (Diluted)

$1.11

Cash Flow

Operating Cash Flow

$114M

Free Cash Flow

$114M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$418M

Total Liabilities

$301M

Stockholders' Equity

$117M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$322M	$63M	+409.5%
Gross Profit	$319M	$61M	+425.1%
Operating Income	$141M	-$103M	+237.0%
Net Income	$130M	-$121M	+208.0%